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grade. Peri-operative stroke rate was 1.2%.
Conclusion: Carotid endarterectomy for symptomatic high
grade carotid artery stenosis is carried out in our institution
with acceptable peri-operative stroke rates and time inter-
val to surgery. The centralisation of acute surgical services
and availability of an emergency theatre, timely access to
imaging and the availability of a stroke nurse coordinator
may have facilitated faster access to surgery. Carotid disease
is best managed with a multidisciplinary approach.
Abdominal Aortic Aneurysm Repair in the Presence of a
Stoma
A.S. Galbraith, E.M. Quinn, M.P. McMonagle, K.S. Cross
Department of Vascular and General Surgery, University Hospital Waterford,
Ireland
A 67 year old gentleman presented to an emergency
department with acute abdominal pain and an underlying
diagnosis of known abdominal aortic aneurysm (AAA).
Subsequent transfer to a tertiary centre for immediate open
aneurysmal repair was undertaken. At the time of surgery a
segment of ischaemic bowel extending from mid-transverse
to distal sigmoid colon was discovered and no evidence of
aneurysmal leakage. Successful left hemi-colectomy was
performed, end-colostomy fashioned and aneurysmal repair
postponed. Elective open AAA repair of an 8.5cm aneurysm
was undertaken eight weeks post initial laparotomy. This
patient’s postoperative course was unfortunately compli-
cated by Dacron graft infection, the need for explantation of
the graft and further surgery following which the patient
was successfully discharged home.
We present an interesting case of AAA repair in the
presence of a recent colostomy for ischaemic bowel, which
poses signiﬁcant challenges intra and post-operatively for
both surgeon and patient. It raises issues including; appro-
priate timing of procedure, anecdotal reports of aneurysm
expansion following laparotomy, difﬁculties maintaining
surgical site sterility, the possible use of extended prophy-
lactic antibiotic administration and the management of the
potential dreaded prosthetic graft infection, all in the pres-
ence of an imminently life threatening condition.
In conclusion complex major vascular procedures in the
presence of concomitant intra-abdominal pathology pose
an array of signiﬁcant dilemmas to which there are no
simple solutions.
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85054, United StatesIntroduction: Robotic surgery has been widely adopted in
urological, gynaecological and now colorectal surgery.
However, clinicians still remain apprehensive when vascular
structures are involved. The objective of this study was to
describe our initial experience with robotic surgery of the
inferior vena cava (IVC).
Methods: All patients who underwent robotic surgery of
the IVC between September 2011 and August 2013 were
included. Patient data regarding clinical presentation,
radiological imaging, operative intervention, treatment
pathway and clinical outcome were recorded.
Results: Four patients were identiﬁed (Male ¼ 3, mean age
51.5 years). Three patients with renal tumours (right ¼ 2)
had tumour thrombus extending to the IVC. These three
patients were commenced on therapeutic low-molecular
weight heparin pre-operatively to minimise tumour
thrombus propagation. A fourth female patient presented
with a symptomatic IVC ﬁlter with associated migration
and perforation. All patients proceeded to robotic surgery
with careful patient positioning. After creation of the
pneumoperitoneum, a 12mm camera port was inserted
followed by insertion of the remaining robotic ports under
direct vision (5mm x 1, 8mm x 3 and 12mm x 1). The
operative procedure was performed in stages which
included mobilization of the duodenum and right colon,
IVC dissection, vascular control of the IVC with ligatures
and Rummel tourniquets, creation of cavotomy, mobiliza-
tion and removal of the tumour thrombus or IVC ﬁlter
followed by closure of the cavotomy. Conventional addi-
tional dissection was performed for nephrectomy when
indicated. Mean operative time was 192 minutes with an
IVC clamp time of 78 minutes. Mean total peri-operative
intravenous ﬂuid administration was 4167mls with a cor-
responding urine output of 383mls. All four patients had
uncomplicated post-operative courses with mean
discharge on post-operative day three. Adjuvant chemo-
therapy was administered to all renal tumour patients. All
patients remain well with mean follow-up of nine (range
1e24) months.
Discussion: Our initial experience suggests that robotic IVC
surgery is a valid and safe modality providing satisfactory
access to the IVC leading to shorter recovery and improved
patient quality of life.
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Objectives: Currently, there are no explicit guidelines for
informed consent for vascular surgical interventions. The
objective of this study was to compare current peer-prac-
tice and collate transatlantic consensus relating to vascular
surgery patient consent.
e26 Surgical Trainee Poster AbstractsMethods: A prospective anonymous online survey was
administered to members of the Society for Clinical
Vascular Surgery (SCVS) and the Vascular Surgical Society of
Great Britain and Ireland (VSS). Each member evaluated
general and procedural speciﬁc complications for both
arterial and venous interventions. Greater than 75%
reporting for a speciﬁc complication was deemed the
threshold for consensus opinion.
Results: Overall response rate was 24.8%. The majority of
respondents were attending surgeons (81.5% SCVS vs.
85.2% VSS). Both societies considered senior trainees
competent to obtain consent. The majority of patients were
consented primarily by the attending (67.6% SCVS vs. 90.6%
VSS, p<0.01) on a pre-printed consent form (95.1% SCVS vs.
98.7% VSS). Consent was obtained on the day of surgery in
the ofﬁce (35.4%-SCVS) or the day before surgery in the
hospital ward (35.1%-VSS) with the provision of additional
written documentation (59.2% SCVS vs. 85.4% VSS,
p<0.01). Both societies concurred with documentation of
general complications including bleeding, cardiac, cerebro-
vascular, respiratory, thromboembolic and wound infection
as well as more speciﬁc complications pertaining to aortic
aneurysm, carotid endarterectomy, lower limb bypass,
amputation and venous surgeries. Although the VSS re-
ported a signiﬁcantly higher consent training rate (14.1%
SCVS vs. 40.8% VSS, p<0.01), both societies stated this
mainly involved ad-hoc informal training.
Conclusion: Whilst completion logistics of vascular consent
vary, both SCVS and VSS members concur on the majority of
complications necessary for inclusion in informed vascular
consent.
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Background: Inferior vena cava thrombosis (IVCT) remains
rare with an incidence of 0.4%. We describe our initial
experience with ultrasonic accelerated thrombolysis (UAT)
of IVCT.
Methods: All patients diagnosed with symptomatic IVCT
who were treated with UAT from January 2012 to August
2013 were included. Patient data regarding clinical pre-
sentation, thromboembolic risk factors, pertinent imaging,
treatment pathway and clinical outcome were recorded.
Results: Seven patients (5 males, 2 females, mean age 58.1
years) presented with lower extremity DVT. Four patients
had a history of neoplastic disease and two were current
smokers. Four patients had a history of previous DVT and 6
patients a history of pulmonary emboli. All seven patientswere previously anticoagulated and had IVC ﬁlters in-situ.
Pro-thrombotic haematological analyses were negative for
all patients. Ultrasound duplex imaging identiﬁed proximal
lower extremity thrombus in four patients (57%) while
cross-sectional imaging conﬁrmed thrombus extending
from the iliac veins into the IVC in all seven patients. All
patients were initially treated with limb elevation,
compression hosiery and systemic heparinisation. Signiﬁ-
cantly symptomatic patients proceeded to venography and
evaluation of clot burden. The thrombus was crossed and
bilateral UAT catheters were placed extending into the su-
prarenal IVC. Combined infusions were commenced of
0.5mg tissue plasminogen activator and 35mls of normal
saline coolant via the UAT catheters and 500IU of heparin
via the 7-Fr sheath per hour to each limb separately. After
twenty-four hours, repeat venography was satisfactory in
one patient. The remaining six patients required mechanical
thrombectomy and balloon angioplasty if necessary, which
resulted in satisfactory ﬂow in ﬁve patients. The remaining
patient required an additional twenty-four hour UAT infu-
sion followed by further mechanical thrombectomy before
satisfactory ﬂow was obtained. All patients are currently
well and remain anticoagulated (warfarin ¼ 6,
rivaroxaban ¼ 1) with improvement in lower extremity
symptomatology and no recurrence of IVCT (mean follow-
up 7.6, range 1e20 months).
Conclusions: This is the ﬁrst reported series of UAT for IVCT.
These early results suggest this modality may be helpful in
treating patients with large IVC thrombus burden and sig-
niﬁcant clinical symptoms with successful clot dissolution
and satisfactory venous ﬂow without signiﬁcant patient
distress or complications.
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Introduction, Aims and Methods: At present there does not
appear to be an agreed best practice for management of
expanding type 2 endoleaks following EVAR. Endovascular
coiling seems to be the most prominent in recent years.
With new methods becoming available we aim to review
the outcomes for current practice.
A retrospective case note review of 18 patients was un-
dertaken. PACS, electronic care records & GP notes were
used to assess progression in sac dimension & clinical health.
Results: 88% (16/18) underwent embolization as a deﬁni-
tive procedure. 3 patients died following rupture of AAA
whilst a further 9 died from medical co-morbidities. Mean
time to death in ruptures in these patients was 22 months
vs 49 months in non-ruptured. Sac size on latest scan was
larger in ruptured group (114mm vs 77mm). There was also
on average less interventions on ruptured group (1 vs 1.7).
Mean survival of the remaining 6 patients is 72 months
(43e105) with an average sac size of 60mm.
